• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子受体 2 过表达的乳腺癌细胞中,芳烃受体促进了人表皮生长因子受体 2 配体诱导的细胞迁移。

Heregulin-induced cell migration is promoted by aryl hydrocarbon receptor in HER2-overexpressing breast cancer cells.

机构信息

Department of Molecular Toxicology, Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi, Chiba 274-8510, Japan.

Department of Clinical-Laboratory and Experimental-Research Medicine, Toho University Sakura Medical Center, Shimoshizu 564-1, Sakura, Chiba 285-8741, Japan; Department of Surgical Pathology, Toho University Sakura Medical Center, Shimoshizu 564-1, Sakura, Chiba 285-8741, Japan.

出版信息

Exp Cell Res. 2018 May 1;366(1):34-40. doi: 10.1016/j.yexcr.2018.02.033. Epub 2018 Mar 1.

DOI:10.1016/j.yexcr.2018.02.033
PMID:29501698
Abstract

HER2 overexpression accounts for approximately 15-20% of all breast cancers. We have shown that HER2 overexpression leads to elevated expression of the aryl hydrocarbon receptor (AhR) in breast cancer cells. In this study, firstly, we showed that AhR expression was up-regulated by treatment with the HER3 ligand heregulin (HRG) in HER2-overexpressing breast cancer cell lines. Induction of AhR was mediated by transcriptional activation of the region of AhR promoter corresponding to - 190 to - 100 bp. In addition, HRG treatment elicited nuclear translocation of AhR. To investigate the role of AhR in HRG-HER2/HER3 signaling in HER2-overexpressing cells, we established AhR knockout (KO) HER2-overexpressing cells to perform wound-healing assays. HRG-induced cell migration was markedly attenuated by AhR KO. HRG-induced cell migration was associated with increased expression of the inflammatory cytokines interleukin (IL)-6 and IL-8 in wild type cells, but not in AhR KO cells. These results elucidate that AhR is an important factor for the malignancy in HER2 overexpressing breast cancers.

摘要

HER2 过表达约占所有乳腺癌的 15-20%。我们已经表明,HER2 过表达导致乳腺癌细胞中芳香烃受体 (AhR) 的表达升高。在这项研究中,首先,我们表明,HER2 过表达的乳腺癌细胞系中,HER3 配体 HRG 的处理上调了 AhR 的表达。AhR 的诱导是通过 AhR 启动子区域的转录激活介导的,该区域对应于 -190 到 -100 bp。此外,HRG 处理引发了 AhR 的核转位。为了研究 AhR 在 HRG-HER2/HER3 信号通路中的作用,我们建立了 AhR 敲除 (KO) 的 HER2 过表达细胞,以进行划痕愈合测定。AhR KO 显著减弱了 HRG 诱导的细胞迁移。HRG 诱导的细胞迁移与野生型细胞中炎症细胞因子白细胞介素 (IL)-6 和 IL-8 的表达增加有关,但在 AhR KO 细胞中没有。这些结果表明,AhR 是 HER2 过表达乳腺癌恶性程度的重要因素。

相似文献

1
Heregulin-induced cell migration is promoted by aryl hydrocarbon receptor in HER2-overexpressing breast cancer cells.表皮生长因子受体 2 过表达的乳腺癌细胞中,芳烃受体促进了人表皮生长因子受体 2 配体诱导的细胞迁移。
Exp Cell Res. 2018 May 1;366(1):34-40. doi: 10.1016/j.yexcr.2018.02.033. Epub 2018 Mar 1.
2
HER2 overexpression-mediated inflammatory signaling enhances mammosphere formation through up-regulation of aryl hydrocarbon receptor transcription.HER2 过表达介导的炎症信号通过上调芳香烃受体转录增强乳腺球形成。
Cancer Lett. 2013 Mar 1;330(1):41-8. doi: 10.1016/j.canlet.2012.11.021. Epub 2012 Nov 27.
3
Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretion.HER2和HER3受体酪氨酸激酶的共表达通过刺激白细胞介素-8自分泌增强乳腺细胞的侵袭。
Breast Cancer Res. 2012 Oct 12;14(5):R131. doi: 10.1186/bcr3329.
4
A functional comparison between the HER2(high)/HER3 and the HER2(low)/HER3 dimers on heregulin-β1-induced MMP-1 and MMP-9 expression in breast cancer cells.在乳腺癌细胞中,针对表皮生长因子受体 2(HER2)高表达/HER3 二聚体和 HER2 低表达/HER3 二聚体,比较它们在人表皮生长因子受体 3 配体(heregulin-β1)诱导的基质金属蛋白酶 1(MMP-1)和基质金属蛋白酶 9(MMP-9)表达方面的功能。
Exp Mol Med. 2012 Aug 31;44(8):473-82. doi: 10.3858/emm.2012.44.8.054.
5
Study of inhibition effect of herceptin on interaction between heregulin and erbB receptors HER3/HER2 by single-molecule force spectroscopy.通过单分子力谱研究赫赛汀对神经调节蛋白与erbB受体HER3/HER2之间相互作用的抑制作用。
Exp Cell Res. 2009 Oct 1;315(16):2847-55. doi: 10.1016/j.yexcr.2009.05.023. Epub 2009 Jun 1.
6
HRG/HER2/HER3 signaling promotes AhR-mediated Memo-1 expression and migration in colorectal cancer.HRG/HER2/HER3信号通路促进芳烃受体介导的Memo-1表达及结直肠癌细胞迁移。
Oncogene. 2017 Apr 27;36(17):2394-2404. doi: 10.1038/onc.2016.390. Epub 2016 Dec 12.
7
Possible Involvement of the Upregulation of ΔNp63 Expression Mediated by HER2-Activated Aryl Hydrocarbon Receptor in Mammosphere Maintenance.可能涉及由 HER2 激活的芳香烃受体介导的 ΔNp63 表达上调在乳腺球维持中的作用。
Int J Mol Sci. 2022 Oct 11;23(20):12095. doi: 10.3390/ijms232012095.
8
Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cells.二甲双胍通过抑制HER2和HER3信号通路对他莫昔芬耐药乳腺癌细胞产生抗癌作用。
Tumour Biol. 2016 May;37(5):5811-9. doi: 10.1007/s13277-015-4440-9. Epub 2015 Nov 18.
9
The HER2- and heregulin β1 (HRG)-inducible TNFR superfamily member Fn14 promotes HRG-driven breast cancer cell migration, invasion, and MMP9 expression.HER2 和人表皮生长因子受体 3(HRG)诱导的肿瘤坏死因子受体超家族成员 Fn14 促进 HRG 驱动的乳腺癌细胞迁移、侵袭和 MMP9 表达。
Mol Cancer Res. 2013 Apr;11(4):393-404. doi: 10.1158/1541-7786.MCR-12-0542. Epub 2013 Feb 1.
10
Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast Cancer.Heregulin 通过改变 ER 阳性乳腺癌中的 IL-8 表达来驱动内分泌耐药。
Int J Mol Sci. 2020 Oct 19;21(20):7737. doi: 10.3390/ijms21207737.

引用本文的文献

1
Anticancer Potential of Indole Phytoalexins and Their Analogues.吲哚植物抗毒素及其类似物的抗癌潜力。
Molecules. 2024 May 19;29(10):2388. doi: 10.3390/molecules29102388.
2
Unlocking the secrets: exploring the influence of the aryl hydrocarbon receptor and microbiome on cancer development.解锁秘密:探索芳香烃受体和微生物组对癌症发展的影响。
Cell Mol Biol Lett. 2024 Mar 6;29(1):33. doi: 10.1186/s11658-024-00538-0.
3
Aryl hydrocarbon receptor: An emerging player in breast cancer pathogenesis and its potential as a drug target (Review).
芳香烃受体:乳腺癌发病机制中的一个新兴参与者及其作为药物靶点的潜力(综述)。
Mol Med Rep. 2024 Jan;29(1). doi: 10.3892/mmr.2023.13134. Epub 2023 Nov 24.
4
The Role of the Aryl Hydrocarbon Receptor (AhR) and Its Ligands in Breast Cancer.芳烃受体(AhR)及其配体在乳腺癌中的作用
Cancers (Basel). 2022 Nov 14;14(22):5574. doi: 10.3390/cancers14225574.
5
Possible Involvement of the Upregulation of ΔNp63 Expression Mediated by HER2-Activated Aryl Hydrocarbon Receptor in Mammosphere Maintenance.可能涉及由 HER2 激活的芳香烃受体介导的 ΔNp63 表达上调在乳腺球维持中的作用。
Int J Mol Sci. 2022 Oct 11;23(20):12095. doi: 10.3390/ijms232012095.
6
Camalexin, an indole phytoalexin, inhibits cell proliferation, migration, and mammosphere formation in breast cancer cells via the aryl hydrocarbon receptor.卡马西林是一种吲哚植物抗毒素,通过芳香烃受体抑制乳腺癌细胞的增殖、迁移和类器官形成。
J Nat Med. 2022 Jan;76(1):110-118. doi: 10.1007/s11418-021-01560-8. Epub 2021 Aug 31.
7
A New Insight into the Potential Role of Tryptophan-Derived AhR Ligands in Skin Physiological and Pathological Processes.色氨酸衍生的 AhR 配体在皮肤生理和病理过程中的潜在作用的新见解。
Int J Mol Sci. 2021 Jan 22;22(3):1104. doi: 10.3390/ijms22031104.
8
Environmental chemicals, breast cancer progression and drug resistance.环境化学物质、乳腺癌进展和耐药性。
Environ Health. 2020 Nov 17;19(1):117. doi: 10.1186/s12940-020-00670-2.
9
Pretreatment with Gemcitabine/5-Fluorouracil Enhances the Cytotoxicity of Trastuzumab to HER2-Negative Human Gallbladder Cancer Cells In Vitro and In Vivo.吉西他滨/5-氟尿嘧啶预处理增强曲妥珠单抗对 HER2 阴性人胆囊癌细胞的体外和体内细胞毒性。
Biomed Res Int. 2019 Mar 25;2019:9205851. doi: 10.1155/2019/9205851. eCollection 2019.
10
Towards Resolving the Pro- and Anti-Tumor Effects of the Aryl Hydrocarbon Receptor.探讨芳香烃受体的促癌和抑癌作用。
Int J Mol Sci. 2018 May 7;19(5):1388. doi: 10.3390/ijms19051388.